Shares of Endologix, Inc. (NASDAQ:ELGX) have been assigned a consensus recommendation of “Buy” from the eleven brokerages that are presently covering the stock, Market Beat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company. The […]